FDA Announces Joint Meeting of Advisory Committees for Nonprescription Drugs and Drug Safety

Summary

The Food and Drug Administration (FDA) is hosting a joint meeting of the Nonprescription Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee to provide advice on FDA's regulatory issues, with a public docket for comments